Report Detail
Global Novel Drug Delivery Systems Market Growth 2019-2024
- RnM3072368 |
- 07 March, 2019 |
- Global |
- 176 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
The classification of Novel Drug Delivery Systems includes Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, and the proportion of PEGylated Proteins & Polypeptides in 2017 is about 39.60%, and the proportion is in decreasing trend from 2013 to 2017.
North America is the largest consumption place, with a consumption market share nearly 49.69% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26.15%.
According to this study, over the next five years the Novel Drug Delivery Systems market will register a 2.2% CAGR in terms of revenue, the global market size will reach US$ 30300 million by 2024, from US$ 26500 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Novel Drug Delivery Systems business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Novel Drug Delivery Systems market by product type, application, key manufacturers and key regions and countries.
This study considers the Novel Drug Delivery Systems value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals & Clinic
Cancer Treatment Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amgen
Teva
UCB (Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
TOLMAR
Astellas
AMAG Pharmaceuticals
AstraZeneca
AbbVie
Bausch＆Lomb
TWi Pharmaceuticals
Novartis
Aspen
Shire
Breckenridge Pharmaceuticals
Galen
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Novel Drug Delivery Systems consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Novel Drug Delivery Systems market by identifying its various subsegments.
Focuses on the key global Novel Drug Delivery Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Novel Drug Delivery Systems with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Novel Drug Delivery Systems submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Novel Drug Delivery Systems Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Novel Drug Delivery Systems Consumption 2014-2024
- 2.1.2 Novel Drug Delivery Systems Consumption CAGR by Region
- 2.2 Novel Drug Delivery Systems Segment by Type
- 2.2.1 Liposomes
- 2.2.2 PEGylated Proteins & Polypeptides
- 2.2.3 Polymer Nanoparticle
- 2.2.4 Protein–drug Conjugates
- 2.2.5 Others
- 2.3 Novel Drug Delivery Systems Consumption by Type
- 2.3.1 Global Novel Drug Delivery Systems Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Novel Drug Delivery Systems Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Novel Drug Delivery Systems Sale Price by Type (2014-2019)
- 2.4 Novel Drug Delivery Systems Segment by Application
- 2.4.1 Hospitals & Clinic
- 2.4.2 Cancer Treatment Centers
- 2.4.3 Others
- 2.5 Novel Drug Delivery Systems Consumption by Application
- 2.5.1 Global Novel Drug Delivery Systems Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Novel Drug Delivery Systems Value and Market Share by Application (2014-2019)
- 2.5.3 Global Novel Drug Delivery Systems Sale Price by Application (2014-2019)
3 Global Novel Drug Delivery Systems by Players
- 3.1 Global Novel Drug Delivery Systems Sales Market Share by Players
- 3.1.1 Global Novel Drug Delivery Systems Sales by Players (2017-2019)
- 3.1.2 Global Novel Drug Delivery Systems Sales Market Share by Players (2017-2019)
- 3.2 Global Novel Drug Delivery Systems Revenue Market Share by Players
- 3.2.1 Global Novel Drug Delivery Systems Revenue by Players (2017-2019)
- 3.2.2 Global Novel Drug Delivery Systems Revenue Market Share by Players (2017-2019)
- 3.3 Global Novel Drug Delivery Systems Sale Price by Players
- 3.4 Global Novel Drug Delivery Systems Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Novel Drug Delivery Systems Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Novel Drug Delivery Systems Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Novel Drug Delivery Systems by Regions
- 4.1 Novel Drug Delivery Systems by Regions
- 4.1.1 Global Novel Drug Delivery Systems Consumption by Regions
- 4.1.2 Global Novel Drug Delivery Systems Value by Regions
- 4.2 Americas Novel Drug Delivery Systems Consumption Growth
- 4.3 APAC Novel Drug Delivery Systems Consumption Growth
- 4.4 Europe Novel Drug Delivery Systems Consumption Growth
- 4.5 Middle East & Africa Novel Drug Delivery Systems Consumption Growth
5 Americas
- 5.1 Americas Novel Drug Delivery Systems Consumption by Countries
- 5.1.1 Americas Novel Drug Delivery Systems Consumption by Countries (2014-2019)
- 5.1.2 Americas Novel Drug Delivery Systems Value by Countries (2014-2019)
- 5.2 Americas Novel Drug Delivery Systems Consumption by Type
- 5.3 Americas Novel Drug Delivery Systems Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Novel Drug Delivery Systems Consumption by Countries
- 6.1.1 APAC Novel Drug Delivery Systems Consumption by Countries (2014-2019)
- 6.1.2 APAC Novel Drug Delivery Systems Value by Countries (2014-2019)
- 6.2 APAC Novel Drug Delivery Systems Consumption by Type
- 6.3 APAC Novel Drug Delivery Systems Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Novel Drug Delivery Systems by Countries
- 7.1.1 Europe Novel Drug Delivery Systems Consumption by Countries (2014-2019)
- 7.1.2 Europe Novel Drug Delivery Systems Value by Countries (2014-2019)
- 7.2 Europe Novel Drug Delivery Systems Consumption by Type
- 7.3 Europe Novel Drug Delivery Systems Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Novel Drug Delivery Systems by Countries
- 8.1.1 Middle East & Africa Novel Drug Delivery Systems Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Novel Drug Delivery Systems Value by Countries (2014-2019)
- 8.2 Middle East & Africa Novel Drug Delivery Systems Consumption by Type
- 8.3 Middle East & Africa Novel Drug Delivery Systems Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Novel Drug Delivery Systems Distributors
- 10.3 Novel Drug Delivery Systems Customer
11 Global Novel Drug Delivery Systems Market Forecast
- 11.1 Global Novel Drug Delivery Systems Consumption Forecast (2019-2024)
- 11.2 Global Novel Drug Delivery Systems Forecast by Regions
- 11.2.1 Global Novel Drug Delivery Systems Forecast by Regions (2019-2024)
- 11.2.2 Global Novel Drug Delivery Systems Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Novel Drug Delivery Systems Forecast by Type
- 11.8 Global Novel Drug Delivery Systems Forecast by Application
12 Key Players Analysis
- 12.1 Amgen
- 12.1.1 Company Details
- 12.1.2 Novel Drug Delivery Systems Product Offered
- 12.1.3 Amgen Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Amgen News
- 12.2 Teva
- 12.2.1 Company Details
- 12.2.2 Novel Drug Delivery Systems Product Offered
- 12.2.3 Teva Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Teva News
- 12.3 UCB (Union Chimique Belge)
- 12.3.1 Company Details
- 12.3.2 Novel Drug Delivery Systems Product Offered
- 12.3.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 UCB (Union Chimique Belge) News
- 12.4 Roche
- 12.4.1 Company Details
- 12.4.2 Novel Drug Delivery Systems Product Offered
- 12.4.3 Roche Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Roche News
- 12.5 Celgene
- 12.5.1 Company Details
- 12.5.2 Novel Drug Delivery Systems Product Offered
- 12.5.3 Celgene Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Celgene News
- 12.6 Sanofi
- 12.6.1 Company Details
- 12.6.2 Novel Drug Delivery Systems Product Offered
- 12.6.3 Sanofi Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Sanofi News
- 12.7 Merck
- 12.7.1 Company Details
- 12.7.2 Novel Drug Delivery Systems Product Offered
- 12.7.3 Merck Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Merck News
- 12.8 Johnson & Johnson
- 12.8.1 Company Details
- 12.8.2 Novel Drug Delivery Systems Product Offered
- 12.8.3 Johnson & Johnson Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Johnson & Johnson News
- 12.9 Takeda
- 12.9.1 Company Details
- 12.9.2 Novel Drug Delivery Systems Product Offered
- 12.9.3 Takeda Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Takeda News
- 12.10 Gilead Sciences
- 12.10.1 Company Details
- 12.10.2 Novel Drug Delivery Systems Product Offered
- 12.10.3 Gilead Sciences Novel Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Gilead Sciences News
- 12.11 Pfizer
- 12.12 Dr Reddy
- 12.13 Samyang Biopharmaceuticals
- 12.14 TOLMAR
- 12.15 Astellas
- 12.16 AMAG Pharmaceuticals
- 12.17 AstraZeneca
- 12.18 AbbVie
- 12.19 Bausch＆Lomb
- 12.20 TWi Pharmaceuticals
- 12.21 Novartis
- 12.22 Aspen
- 12.23 Shire
- 12.24 Breckenridge Pharmaceuticals
- 12.25 Galen
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Novel Drug Delivery Systems. Industry analysis & Market Report on Novel Drug Delivery Systems is a syndicated market report, published as Global Novel Drug Delivery Systems Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Novel Drug Delivery Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
